Plain-English translation of NCT06576934 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing whether a minimally invasive procedure called a transjugular intrahepatic portosystemic shunt (TIPS) should be placed earlier in patients with liver cirrhosis and ascites—rather than waiting until standard treatments like diuretics and fluid drainage fail. The procedure creates a small channel to redirect blood flow around the scarred liver, which may help control fluid buildup more effectively and improve overall outcomes.
Standard treatment for ascites (fluid buildup from liver disease) works in only about half of patients, and those who need repeated fluid draining procedures have worse outcomes. Recent evidence suggests that placing this shunt earlier—similar to how it's already used in emergency bleeding situations—might prevent complications and help more patients control their ascites without repeated procedures.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of two groups: either receiving the TIPS procedure or receiving standard medical treatment (salt restriction, water pills, and fluid drainage procedures if needed). If you receive the TIPS procedure, you'll have an interventional radiology procedure where a small catheter is placed through a vein to create the shunt. You'll be monitored during the trial to see how well each approach controls your ascites, prevents complications, and affects your overall health. Your doctor will explain the specific timeline and follow-up visits for your group.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
Germany